Internal surgical staplers made headline news in 2019. Reports discussed the little-known US Food and Drug Administration database housing tens of thousands of stapler-related problem reports and covered the agency’s recent proposal to reclassify staplers as Class II devices, instead of the more lightly regulated Class I.
Next-Gen Disruptors: Technologies Transforming the OR Installment #1, presented by…
The promise of quicker recovery and fewer complications from sedation,…
Critical assessment and rapid response are essentials skills for perioperative…